185 related articles for article (PubMed ID: 9684890)
1. Cloning, expression, and purification of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase: crystallization of nucleic acid complexes.
Sun D; Jessen S; Liu C; Liu X; Najmudin S; Georgiadis MM
Protein Sci; 1998 Jul; 7(7):1575-82. PubMed ID: 9684890
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
3. Structural and energetic characterization of nucleic acid-binding to the fingers domain of Moloney murine leukemia virus reverse transcriptase.
Crowther RL; Remeta DP; Minetti CA; Das D; Montano SP; Georgiadis MM
Proteins; 2004 Oct; 57(1):15-26. PubMed ID: 15326591
[TBL] [Abstract][Full Text] [Related]
4. A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase.
Das D; Georgiadis MM
Protein Sci; 2001 Oct; 10(10):1936-41. PubMed ID: 11567084
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase.
Georgiadis MM; Jessen SM; Ogata CM; Telesnitsky A; Goff SP; Hendrickson WA
Structure; 1995 Sep; 3(9):879-92. PubMed ID: 8535782
[TBL] [Abstract][Full Text] [Related]
6. Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation.
Konishi A; Hisayoshi T; Yokokawa K; Barrioluengo V; Menéndez-Arias L; Yasukawa K
Biochem Biophys Res Commun; 2014 Nov; 454(2):269-74. PubMed ID: 25450388
[TBL] [Abstract][Full Text] [Related]
7. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
[TBL] [Abstract][Full Text] [Related]
8. Use of an N-terminal fragment from moloney murine leukemia virus reverse transcriptase to facilitate crystallization and analysis of a pseudo-16-mer DNA molecule containing G-A mispairs.
Coté ML; Yohannan SJ; Georgiadis MM
Acta Crystallogr D Biol Crystallogr; 2000 Sep; 56(Pt 9):1120-31. PubMed ID: 10957631
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
[TBL] [Abstract][Full Text] [Related]
10. Structure of a pseudo-16-mer DNA with stacked guanines and two G-A mispairs complexed with the N-terminal fragment of Moloney murine leukemia virus reverse transcriptase.
Coté ML; Georgiadis MM
Acta Crystallogr D Biol Crystallogr; 2001 Sep; 57(Pt 9):1238-50. PubMed ID: 11526315
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of Moloney murine leukemia virus reverse transcriptase. Demonstration of lysine 103 in the nucleotide binding site.
Basu A; Basu S; Modak MJ
J Biol Chem; 1990 Oct; 265(28):17162-6. PubMed ID: 1698772
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus.
Das D; Georgiadis MM
Structure; 2004 May; 12(5):819-29. PubMed ID: 15130474
[TBL] [Abstract][Full Text] [Related]
13. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
14. Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract x-rays to 3.5-A resolution.
Jacobo-Molina A; Clark AD; Williams RL; Nanni RG; Clark P; Ferris AL; Hughes SH; Arnold E
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10895-9. PubMed ID: 1720554
[TBL] [Abstract][Full Text] [Related]
15. Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity.
Kotewicz ML; Sampson CM; D'Alessio JM; Gerard GF
Nucleic Acids Res; 1988 Jan; 16(1):265-77. PubMed ID: 2448747
[TBL] [Abstract][Full Text] [Related]
16. A novel and simple method for high-level production of reverse transcriptase from Moloney murine leukemia virus (MMLV-RT) in Escherichia coli.
Chen Y; Xu W; Sun Q
Biotechnol Lett; 2009 Jul; 31(7):1051-7. PubMed ID: 19330487
[TBL] [Abstract][Full Text] [Related]
17. RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.
Telesnitsky A; Goff SP
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1276-80. PubMed ID: 7679498
[TBL] [Abstract][Full Text] [Related]
18. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
Goedken ER; Marqusee S
Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.
Agbuya PG; Sherman NE; Moen LK
Arch Biochem Biophys; 2001 Aug; 392(1):93-102. PubMed ID: 11469799
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labeling of the primer binding domain in murine leukemia virus reverse transcriptase.
Tirumalai RS; Modak MJ
Biochemistry; 1991 Jul; 30(26):6436-43. PubMed ID: 1711370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
